NCT01475032View on ClinicalTrials.gov

"Efficacy Study of the Product CHF 1535 Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children"

PHASE3CompletedINTERVENTIONAL
Enrollment

638

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Asthma
Interventions
DRUG

CHF 1535

CHF 1535 (BDP/FF) for 12 weeks

DRUG

Beclomethasone (BDP)

Beclomethasone (BDP) for 12 weeks

DRUG

Beclomethasone (BDP) + Formoterol Fumarate (FF)

free combo Beclomethasone (BDP) + FF for 12 weeks

Trial Locations (11)

4002

"UMHAT Alexandrovska", Plovdiv

7900

Micro Care Kft, Szigetvár

16147

G.Gaslini Institute, Genoa

75015

Necker Enfants Malades Hospital, Paris

Drez. Gelb & Knecht, Bretten

119435

Moscow State Medical University, Moscow

22 90-153

Uniwersytetu Medycznego, Lodz

011461

Spitalul Clinic Universitar de Urgenta Elias, Bucharest

059 81

NZZ- Detská pneumologická a ftizeologická ambulanci, Dolný Smokovec

Unknown

Hospital de Sabadell, Barcelona

04050

Institute of Pediatrics, Kyiv

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01475032 - "Efficacy Study of the Product CHF 1535 Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children" | Biotech Hunter | Biotech Hunter